Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunologic Deficiency Syndrome, Acquired”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT02938377
What this trial is testing

Alcohol Research Consortium in HIV-Intervention Research Arm

Who this might be right for
HIV PositiveAlcohol Use
University of Alabama at Birmingham 4,985
Early research (Phase 1)Study completedNCT00712530
What this trial is testing

Single DermaVir Immunization in HIV-1 Infected Patients on HAART

Who this might be right for
HIV Infection
Genetic Immunity 9
Early research (Phase 1)Study completedNCT02345707
What this trial is testing

Relative Bioavailability Study of Phase III Tablet Formulation of Cabotegravir

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 37
Not applicableStudy completedNCT02301507
What this trial is testing

Study of Cell Phone SMS to Improve Adherence to ART in HIV Positive Young Women

Who this might be right for
HIV Infection
The University of Texas Health Science Center, Houston 7
Not applicableStudy completedNCT01813292
What this trial is testing

Fluoride Metabolism, Bone Remodelling and Mineral Density in HIV Patients Treated With Tenofovir +/- Emtricitabine

Who this might be right for
HIV Seropositivity
Hopital Lariboisière 103
Testing effectiveness (Phase 2)Study completedNCT00002131
What this trial is testing

A Pilot Study of OPC-8212 (Vesnarinone) in Persons With AIDS-Related Kaposi's Sarcoma

Who this might be right for
Sarcoma, KaposiHIV Infections
Otsuka America Pharmaceutical 28
Large-scale testing (Phase 3)Study completedNCT00002445
What this trial is testing

Safety and Effectiveness of an Experimental Drug, IM862, in Treating Kaposi's Sarcoma in AIDS Patients

Who this might be right for
Sarcoma, KaposiHIV Infections
Cytran 200
Large-scale testing (Phase 3)Study completedNCT03311945
What this trial is testing

Simplification Study of HIV-1 Infected Patients With Virological Suppression Under the Combination of Lamivudine (150 mg BID) Plus Raltegravir (400 mg BID) Switching to Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) : Roll-over Study of the RALAM

Who this might be right for
HIV InfectionsHIV-1-infectionHIV Seropositivity
Judit Pich 33
Early research (Phase 1)Study completedNCT01016730
What this trial is testing

Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma

Who this might be right for
AIDS-Related Kaposi SarcomaHIV InfectionRecurrent Kaposi Sarcoma
National Cancer Institute (NCI) 24
Early research (Phase 1)Study completedNCT00000865
What this trial is testing

The Safety and Effects of 1592U89 Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Infants and Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 32
Early research (Phase 1)Study completedNCT00000977
What this trial is testing

Active Immunization of Asymptomatic, HIV-Infected Individuals With Recombinant GP160 HIV-1 Antigen: A Phase I/II Study of Immunogenicity and Toxicity

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 52
Testing effectiveness (Phase 2)Study completedNCT00000781
What this trial is testing

A Randomized, Double-Blind, Four-Arm Study Comparing Combination Nucleoside, Alternating Nucleoside, and Triple-Drug Therapy for the Treatment of Advanced HIV Disease (CD4 <= 50/mm3)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 1,292
Early research (Phase 1)UnknownNCT01881581
What this trial is testing

Safety and Immunogenicity of Recombinant HIV Vaccines for HIV/AIDS

Who this might be right for
Acquired Immunodeficiency Syndrome
Centers for Disease Control and Prevention, China 56
Large-scale testing (Phase 3)Study completedNCT01077765
What this trial is testing

Polyacrylamide Hydrogel Injection in HIV-related Lipoatrophy

Who this might be right for
HIV InfectionAntiretroviral Side EffectsLipodystrophy Syndrome Related to HIV Infection
Assistance Publique - Hôpitaux de Paris 100
Early research (Phase 1)Study completedNCT01138072
What this trial is testing

A Drug Interaction Study Between Simvastatin, Atorvastatin, Rosuvastatin, and GSK2248761 in Healthy Subjects.

Who this might be right for
Infection, Human Immunodeficiency Virus
GlaxoSmithKline 14
Not applicableStudy completedNCT02277795
What this trial is testing

Evaluation of the AccuCirc for Early Infant Male Circumcision in Nyanza, Kenya

Who this might be right for
Male Circumcision
Brigham and Women's Hospital 704
Not applicableStudy completedNCT04357639
What this trial is testing

Impact of Long-term Protease Inhibitors in Patients Living With HIV on the Incidence of COVID-19 ( COVIP )

Who this might be right for
HIV Patients
Centre Hospitalier Intercommunal Creteil 1,040
Post-approval studies (Phase 4)Study completedNCT00543101
What this trial is testing

Efficacy Study of Substitution of Darunavir/Ritonavir (DRV/r) for Dual-boosted Protease Inhibitors

Who this might be right for
HIV Infections
Community Research Initiative of New England 24
Early research (Phase 1)Study completedNCT00582101
What this trial is testing

Family-Based HIV Prevention for Latinos

Who this might be right for
HIV Infections
Rhode Island Hospital 80
Large-scale testing (Phase 3)Study completedNCT02103439
What this trial is testing

An Open-label Randomized Multicenter Phase III Clinical Study Comparing Safety and Efficacy of Algeron (Cepeginterferon Alfa-2b) and and PegIntron (Peginterferon Alfa-2b) in Combination With Ribavirin as Combined Treatment of Chronic Hepatitis C in Human Immunodeficiency Virus-1 Infected Patients

Who this might be right for
HepatitisHepatitis CHepatitis C/ Human Immunodeficiency Virus Coinfection
Biocad 140
Next Page